Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Aug 1995, 2082-2085, Vol 33, No. 8
LM Godsel, RS Tibbetts, CL Olson, BM Chaudoir and DM Engman
The protozoan Trypanosoma cruzi is the causative agent of Chagas' disease,
a major public health problem in Latin America and of growing concern in
the United States as the number of infected immigrants increases. There is
currently no testing of U.S. blood products for T. cruzi infection, and the
best tests available, although highly sensitive, are not of high enough
specificity to be useful for widespread screening of the blood supply in
this country. Among the parasite antigens detected by sera of infected
humans and mice, those in the range of 24 to 26 kDa are particularly
reactive. With an aim of developing a sensitive, specific, recombinant
antigen-based serologic test for T. cruzi infection, we used two antibody
reagents specific for these 24- to 26-kDa antigens to isolate cDNA clones
from a T. cruzi expression library. One clone was found to encode a
previously characterized T. cruzi antigen, a 24-kDa flagellar
calcium-binding protein (FCaBP). Recombinant FCaBP was found to be a
sensitive, specific reagent for distinguishing T. cruzi-infected
individuals from uninfected persons, and it therefore could potentially be
used for screening purposes, especially if combined with other recombinant
T. cruzi antigens that have similarly high degrees of diagnostic
sensitivity and specificity.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»